Article Text

PDF

PS-163 Adult Survivors Of Intrauterine Transfusion For Rhesus Disease Have Health And Socioeconomic Status Similar To Unaffected Siblings
  1. AH Wallace1,
  2. SR Dalziel2,
  3. KL Thornburg3,
  4. JE Harding1
  1. 1Liggins Institute, University of Auckland, Auckland, New Zealand
  2. 2Children’s Emergency Department, Starship Children’s Hospital, Auckland, New Zealand
  3. 3Heart Research Center, Oregon Health and Sciences University, Portland, USA

Abstract

Background and aims Intrauterine transfusion for rhesus disease is not uncommon, but long-term health and socioeconomic status in adulthood have not previously been reported. This study aimed to compare these outcomes in adult survivors of intrauterine transfusion to that of unaffected siblings.

Methods Participants were adults who received intrauterine transfusion for rhesus disease, and their unaffected sibling (s). Data regarding socioeconomic status, lifestyle and medical history were collected and compared using Chi-squared and T-tests.

Results Affected participants (n = 95) were younger than unaffected (n = 92) (mean ± SD 33.7 ± 9.3 vs 40.1 ± 10.9 years, p < 0.001) and born at lower gestation (34.5 ± 1.6 vs 39.5 ± 2.1 weeks, p < 0.001) but similar in sex distribution (%male: 54% affected vs 45% unaffected, p = 0.21). There were no differences between groups in socioeconomic status and lifestyle variables (Table 1), or health outcomes (Table 2).

Abstract PS-163 Table 1
Abstract PS-163 Table 2

Conclusions This study provides the first evidence that survivors of intrauterine transfusion for rhesus disease show no evidence of adverse effects on general health or socioeconomic status in early to middle adulthood.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.